Drug intelligence / Profile preview

Kehuang capsule

Development stage: Preclinical
Lead developer: Kexing Biopharm
Administration: Oral

Overview

**Kehuang capsule** is an oral traditional Chinese medicine product manufactured by Kexing Biopharmaceutical. It is a chemically heterogeneous herbal and fermentation-derived preparation made using solid-state fermentation of *Monascus purpureus*. A multicenter, randomized, double-blind, placebo-controlled post-marketing trial has evaluated the capsule for nonalcoholic fatty liver disease with damp-heat accumulation syndrome. Its molecular pharmacology and direct biological targets have not been established in the available public sources.

Brand names: Tongantang
Other names: Kehuang CapsuleKelong capsule克癀胶囊

Beyond the preview

Go deeper on Kehuang capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kehuang capsule.

Explore the full profile